Surgical treatments and therapies for atrial fibrillation
Search documents
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
Businesswire· 2026-01-12 15:21
Core Viewpoint - AtriCure, Inc. announced preliminary financial results for Q4 2025, indicating a revenue growth of approximately 13% compared to the same quarter in the previous year, with expected revenue of $140.5 million [1] Financial Performance - Preliminary, unaudited revenue for Q4 2025 is projected to be $140.5 million [1] - This represents a growth of around 13% over Q4 2024 [1] Future Guidance - AtriCure provided financial guidance for the year 2026, although specific figures were not detailed in the announcement [1]